scroll to top
Your source for trusted research content

EBSCO Auth Banner

Let's find your institution. Click here.

Advanced Search Results For "ADRENERGIC beta blockers"

1 - 10 of 16,943 results for
 "ADRENERGIC beta blockers"
Results per page:

A Clinical-Epidemiological Study on Beta-Blocker Poisonings Based on the Type of Drug Overdose.

Publication Type: Academic Journal

Source(s): Journal of Toxicology. 2/24/2023, p1-7. 7p.

Abstract: Background. Beta‐blockers carry a high risk of potentially causing fatal poisoning if overdosed. We aimed to assess the clinical and epidemiological characteristics of patients with beta-blocker poisoning. Methods. Patients were categorized based on th...

Beta-Blockers for Primary Prevention of Anthracycline-Induced Cardiac Toxicity: An Updated Meta-Analysis of Randomized Clinical Trials.

Publication Type: Academic Journal

Source(s): Cardiovascular Therapeutics. 12/29/2022, p1-13. 13p.

Abstract: Aim. Cardiotoxicity is a well-recognized complication of chemotherapy with Anthracyclines. However, results from trials evaluating beta-blockers for prevention are controversial. Therefore, we performed a meta-analysis to find whether prophylactic admi...

The Role of Systemic and Topical Beta-Blockers in Dermatology: A Systematic Review.

Publication Type: Academic Journal

Source(s): Dermatology & Therapy. Jan2023, Vol. 13 Issue 1, p29-49. 21p.

Abstract: Introduction: Beta-blockers are proven to be safe and cost-effective agents in treating multiple dermatological conditions, which is why they are considered as an interesting and good alternative therapeutic agent by dermatologists. To our knowledge, t...

Paroxysmal Sympathetic Hyperactivity in Moderate-to-Severe Traumatic Brain Injury and the Role of Beta-Blockers: A Scoping Review.

Publication Type: Academic Journal

Source(s): Emergency Medicine International. 9/11/2021, p1-6. 6p.

Abstract: Introduction. Most cases of paroxysmal sympathetic hyperactivity (PSH) result from traumatic brain injury (TBI). Little is known about its pathophysiology and treatment, and several neuroprotective drugs are used including beta-blockers. The aim of our...

Diverse pharmacological properties, trial results, comorbidity prescribing and neural pathophysiology suggest European hypertension guideline downgrading of beta-blockers is not justified.

Publication Type: Academic Journal

Source(s): Blood Pressure. Dec2022, Vol. 31 Issue 1, p210-224. 15p.

Abstract: Beta-blockers have solid documentation in preventing cardiovascular complications in the treatment of hypertension; atenolol, metoprolol, oxprenolol and propranolol demonstrate proven cardiovascular prevention in hypertension mega-trials. Hypertension ...

Impact de la Dapagliflozine sur les paramètres échocardiographiques chez les patients présentant une insuffisance cardiaque à fraction d'éjection réduite : « À propos d'une série monocentrique de 43 cas ».

Publication Type: Academic Journal

Source(s): Annales de Cardiologie et d'Angéiologie. Oct2022, Vol. 71 Issue 4, p203-207. 5p.

Abstract: Le traitement de l'insuffisance cardiaque (IC) à fraction d'éjection réduite < 40 % (HFrEF) fait appel aux règles hygiéno-diététiques associées aux bêtabloquants, bloqueurs du système rénine-angiotensine BSRA (seuls ou associés au sacubitril) et spiron...

Initiation of antihypertensive drugs to patients with confirmed COVID‐19—A population‐based cohort study in Sweden.

Publication Type: Academic Journal

Source(s): Basic & Clinical Pharmacology & Toxicology. Sep2022, Vol. 131 Issue 3, p196-204. 9p.

Abstract: Purpose: Hypertension is an important risk factor for severe outcomes in patients with COVID‐19, and antihypertensive drugs may have a protective effect. However, the pandemic may have negatively impacted health care services for chronic diseases. The ...

Latest Knowledge on the Role of Vitamin D in Hypertension.

Publication Type: Academic Journal

Source(s): International Journal of Molecular Sciences; Mar2023, Vol. 24 Issue 5, p4679, 22p

Abstract: Copyright of International Journal of Molecular Sciences is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print,...

Adrenergic Immune Effects: Is Beta the Enemy of Good?

Publication Type: Academic Journal

Source(s): Critical Care Medicine. Sep2022, Vol. 50 Issue 9, p1415-1418. 4p.

Abstract: Keywords: adrenergic; animals; beta blockers; beta-1-adrenergic; clinical research; immunology; laboratory research; sepsis; T cells; transgenic mice EN adrenergic animals beta blockers beta-1-adrenergic clinical research immunology laboratory research...